Radauer-Plank, Anne-Catherine; Diesch-Furlanetto, Tamara; Schneider, Monika; Sommerhäuser, Greta; Friedrich, Lucía Alácan; Salow, Vivienne; Dülberg, Jill; Diepold, Miriam; Rovó, Alicia; Njue, Linet Muthoni; Drexler, Beatrice; Infanti, Laura; Kroiss, Sabine; Merki, Ramona; Scheinemann, Katrin; Eisenreich, Bernhard; Hegemann, Inga; Mandic, Ljubica; Kager, Leo; Borgmann-Staudt, Anja; ... (2023). Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies. Pediatric blood & cancer, 70(7), e30359. Wiley 10.1002/pbc.30359
|
Text
Pediatric_Blood_Cancer_-_2023_-_Radauer_Plank_-_Desire_for_biological_parenthood_and_patient_counseling_on_the_risk_of.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (290kB) | Preview |
BACKGROUND
Both diagnosis and treatment of hemoglobinopathies have been associated with an increased risk of fertility impairment. German guidelines recommend annual monitoring of fertility parameters to enable early detection of fertility impairment and/or to offer fertility preservation (FP) when indicated. We explored the general desire for parenthood, the frequency of recalling fertility counseling and testing, and the utilization of FP in adolescents and adults with hemoglobinopathies.
PROCEDURE
In a cross-sectional study, patients aged 12-50 years, treated in Germany, Austria, or Switzerland, were surveyed on fertility-related aspects. Medical data, including fertility testing results, were collected from patient records.
RESULTS
Overall, 116/121 eligible patients, diagnosed with sickle cell disease (70.7%), thalassemia (27.6%), or other hemoglobinopathy (1.7%), participated in our study (57.8% female, median age 17.0 years, range 12-50 years). All participants required treatment of the underlying hemoglobinopathy: 68.1% received hydroxyurea, 25.9% required regular blood transfusions, and 6.0% underwent hematopoietic stem cell transplantation (HSCT). Most patients (82/108, 75.9%) stated a considerable to strong desire for (future) parenthood, independent of sex, education, diagnosis, or subjective health status. Fertility counseling was only recalled by 32/111 patients (28.8%) and least frequently by younger patients (12-16 years) or those treated with regular blood transfusions or hydroxyurea. While fertility testing was documented for 59.5% (69/116) in medical records, only 11.6% (13/112) recalled previous assessments. FP was only used by 5.4% (6/111) of patients.
CONCLUSION
Most patients with hemoglobinopathies wish to have biological children, yet only few recalled fertility counseling and testing. Adequate patient counseling should be offered to all patients at risk for infertility.
Actions (login required)
 |
Edit item |